Delivery Order SPE2DB20D1100-SPE2DB24FC7C3

Award Date 7/12/24
Potential Completion Date 7/15/24
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML pharmaceutical products to the Defense Logistics Agency (DLA). The $1,371.23 firm fixed price delivery order was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on June 25, 2024. The contract has a period of performance through June 26, 2024 and does not have any set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML to the Defense Logistics Agency (DLA). The $13,188.88 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of January 23, 2025 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corporation's Corporate Office division, a major pharmaceutical distributor, to provide AIMOVIG 140 mg/mL autoinjectors. The $1,357.86 firm-fixed-price contract has a completion date of July 10, 2024. Amerisourcebergen also holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to deliver a broad range of pharmaceutical products and medical supplies to DLA...
This federal contract award is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The $7,828.00 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on June 5, 2024 with a completion date of June 6, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds two significant Indefinite Delivery Contracts (IDCs) with federal agencies. The...
This federal contract award is for the delivery of Aimovig 70 mg/ml autoinjectors to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on July 24, 2024, with a ceiling value of $1,355.73 and a completion date of July 25, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type and is not designated under any set-aside program. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order with a ceiling value of $18,512.54 for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML. The contract is a firm fixed-price, delivery order awarded by the Defense Logistics Agency (DLA), a defense agency. The ultimate completion date for this contract is November 12, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract has a ceiling value of $4,523.36 and is a firm fixed-price delivery order that runs through June 20, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product. The single-award indefinite delivery contract (IDC) is with the Defense Logistics Agency (DLA) Troop Support Medical and is valued up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA...
This federal contract award is for the delivery of AIMOVIG 70 MG/ML AUTOINJECTORML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,314.66 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of November 15, 2022 and was awarded on November 14, 2022. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $13,170.36 firm fixed-price delivery order has an ultimate completion date of August 16, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between Amerisourcebergen and the...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FC7C3
    Delivery Order

This federal contract award is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded on July 12, 2024 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, and has a ceiling value of $1,357.86. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is July 15, 2024.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense (DoD) worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. The contract does not have a set-aside designation.

Generated 10/11/24, 9:24 AM